Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04538664 |
|---|---|
| Brief Title: | A Study of Combination Amivantamab and Carboplatin-Pemetrexed Therapy, Compared With Carboplatin-Pemetrexed, in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer Characterized by Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions (PAPILLON) |
| First Submitted : | August 31, 2020 |
| First Submitted that Met QC Criteria : | August 31, 2020 |
| First Posted : | September 4, 2020 |
| Last Update Submitted that Met QC Criteria : | May 19, 2022 |
| Last Update Posted : | May 20, 2022 |